Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II clinical trial of Xinlikang Capsule
CTR20260727Phase 2Active
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enalapril in cancer-related fatigue (CRF), colorectal cancer (CRC), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd.. Started Feb 2026; status: active.
02
Drugs
enalapril
03
Conditions
cancer-related fatigue (CRF)colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20260727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260727.